Go Pro
→ My top 3 AI picks for the next decade (From The Oxford Club) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
$9.78
+5.7%		$9.25
$6.79
▼
$41.72
$102.87M1.345,281 shs4,630 shs
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
$107.55
+0.4%		$103.90
$83.76
▼
$108.60
$172.08M0.877,101 shs6,624 shs
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
C$0.15
+3.6%		C$0.13
C$0.11
▼
C$0.23
C$20.08M-0.4784657,447 shs36,000 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
0.00%+3.99%+9.27%-32.60%+5.16%
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
0.00%-0.54%+4.31%+9.55%+26.16%
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
0.00%+3.57%+20.83%+3.57%-36.96%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
$9.78
+5.7%		$9.25
$6.79
▼
$41.72
$102.87M1.345,281 shs4,630 shs
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
$107.55
+0.4%		$103.90
$83.76
▼
$108.60
$172.08M0.877,101 shs6,624 shs
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
C$0.15
+3.6%		C$0.13
C$0.11
▼
C$0.23
C$20.08M-0.4784657,447 shs36,000 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
0.00%+3.99%+9.27%-32.60%+5.16%
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
0.00%-0.54%+4.31%+9.55%+26.16%
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
0.00%+3.57%+20.83%+3.57%-36.96%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
1.00
SellN/AN/A
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
2.42
Hold$107.55N/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest BNR, NSCI, FAB, and APTA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/13/2026
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/31/2026
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
7/17/2026
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
(Data available from 8/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
$77.16M1.33N/AN/A$7.28 per share1.34
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
N/AN/AN/AN/AN/AN/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
C$40.20M0.50C$0.02 per share8.93C$0.21 per share0.69
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
-$7.92M-$0.82N/AN/AN/A-11.57%-10.98%-7.33%9/2/2026 (Estimated)
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
N/AN/A11.94N/AN/AN/AN/AN/AN/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
-C$12.93M-C$0.05N/AN/AN/A-32.75%-38.02%-7.55%N/A

Latest BNR, NSCI, FAB, and APTA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/2/2026Q2 2026
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
-$2.2883N/AN/AN/A$19.21 millionN/A
6/9/2026Q1 2026
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
-$2.2884-$0.20+$2.0884-$0.25$19.21 million$15.66 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
N/AN/AN/AN/AN/A
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
$1.601.49%N/AN/AN/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
N/AN/AN/AN/AN/A

Latest BNR, NSCI, FAB, and APTA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/24/2026
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
quarterly$0.34681.37%6/25/20266/25/20266/30/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
0.06
3.05
2.81
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
N/AN/AN/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
71.72
1.42
1.11

Institutional Ownership

CompanyInstitutional Ownership
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
30.03%
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
N/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
0.03%

Insider Ownership

CompanyInsider Ownership
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
30.30%
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
N/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
3.95%
CompanyEmployeesShares OutstandingFree FloatOptionable
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
1,39010.52 million7.33 millionNot Optionable
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
147,0001.60 millionN/ANot Optionable
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
249138.46 millionN/ANot Optionable

Recent News About These Companies

Nanalysis to Host August 24 Call on Q2 2026 Results
August 18, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/nanalysis-to-host-august-24-call-on-q2-2026-results?utm_source=marketbeat.com&utm_medium=referral
Nanalysis Provides Business Update Highlighting Quantum Technology Partnerships, $1Million in Non-Dilutive Non-Repayable Funding Award, Contract Wins and Corporate Activities
June 23, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/technology/articles/nanalysis-provides-business-highlighting-quantum-210000230.html
Nanalysis Scientific Corp. (NSCI:CA) Q1 2026 Earnings Call Transcript
May 21, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4907585-nanalysis-scientific-corp-nsci-ca-q1-2026-earnings-call-transcript
Nanalysis Scientific Corp.: Nanalysis Announces First Quarter 2026 Results
May 21, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-05/68558470-nanalysis-scientific-corp-nanalysis-announces-first-quarter-2026-results-008.htm
Nanalysis Announces First Quarter 2026 Results
May 21, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/nanalysis-announces-first-quarter-2026-205100721.html
Nanalysis Announces First Quarter 2026 Conference Call
May 14, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/nanalysis-announces-first-quarter-2026-201500505.html
Nanalysis Announces Board Transition and Appointment of Three New Directors
May 1, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/nanalysis-announces-board-transition-appointment-120000984.html
Nanalysis Scientific Corp (NSCIF) Q4 2025 Earnings Call Highlights: Navigating Challenges and ...
April 12, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/nanalysis-scientific-corp-nscif-q4-010016568.html
Nanalysis Scientific Corp.: Nanalysis Announces Fourth Quarter and Full Year 2025 Results
April 9, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-04/68155034-nanalysis-scientific-corp-nanalysis-announces-fourth-quarter-and-full-year-2025-results-008.htm
Nanalysis Scientific Corp. (NSCI:CA) Q4 2025 Earnings Call Prepared Remarks Transcript
April 9, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4889551-nanalysis-scientific-corp-nsci-ca-q4-2025-earnings-call-prepared-remarks-transcript
Nanalysis Sets Date for Q4 and Full-Year 2025 Results Call
April 9, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/NSCIF/pressreleases/1135930/nanalysis-sets-date-for-q4-and-full-year-2025-results-call/
Nanalysis Announces Fourth Quarter and Full Year 2025 Results
April 8, 2026  |  newswire.cahttps://www.newswire.ca/news-releases/nanalysis-announces-fourth-quarter-and-full-year-2025-results-823534379.html
Nanalysis Announces Fourth Quarter and Full Year 2025 Conference Call
April 2, 2026  |  cantechletter.comC
Nanalysis Announces Grant of Options and Restricted Share Units
March 4, 2026  |  cantechletter.comC
Nanalysis Scientific Corp.: Nanalysis Announces Closing of Second Tranche to Complete its $3.4 Million Offering
January 27, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-01/67532875-nanalysis-scientific-corp-nanalysis-announces-closing-of-second-tranche-to-complete-its-dollar-3-4-million-offering-008.htm
Nanalysis Completes $3.4 Million Private Placement with Closing of Second Tranche
January 26, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/nanalysis-completes-3-4-million-private-placement-with-closing-of-second-tranche?utm_source=marketbeat.com&utm_medium=referral
Nanalysis Announces Closing of Second Tranche to Complete its $3.4 Million Offering
January 26, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/nanalysis-announces-closing-second-tranche-211500757.html
Wiley announces Nanalysis Edition of KnowItAll software
January 6, 2026  |  msn.comhttps://www.msn.com/en-gb/money/technology/wiley-announces-nanalysis-edition-of-knowitall-software/ar-AA1TF9zD
Nanalysis upsizes private placement after closing first $2.5 million tranche
December 23, 2025  |  msn.comhttps://www.msn.com/en-us/money/technology/nanalysis-upsizes-private-placement-after-closing-first-2-5-million-tranche/ar-AA1SVEs5
Nanalysis upsizes private placement, closes first tranche
December 23, 2025  |  msn.comhttps://www.msn.com/en-us/money/companies/nanalysis-upsizes-private-placement-closes-first-tranche/ar-AA1SVqnq

Media Sentiment Over Time

Top Headlines

View All Headlines
AMD logo on a glowing processor chip with red circuit traces, highlighting AI and data-center semiconductor demand.
AMD’s AI Bubble Could Burst Into Explosive Upside
By Thomas Hughes | July 27, 2026
SpaceX logo beside a rocket on a launch pad at sunset, with a colorful sky in the background.
SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
By Jeffrey Neal Johnson | August 3, 2026
SoundHound AI logo displayed within a glowing orange ring against a dark background with light wave effects.
SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
By Thomas Hughes | August 10, 2026
Illuminated Fabrinet logo sign beside a fiber-optic transceiver module with green light strands and manufacturing equipment in background.
Fabrinet’s Sell-Off May Prove It Is One of AI’s Most Misunderstood Stocks
By Thomas Hughes | August 18, 2026
Row of illuminated server racks with blue lighting in a data center, reflecting on the polished floor.
AMD’s Helios Launch Could Create Winners Beyond AMD Stock
By Thomas Hughes | August 11, 2026
Burning Rock Biotech stock logo

Burning Rock Biotech NASDAQ:BNR

$9.78 +0.53 (+5.73%)
As of 08/21/2026 04:00 PM Eastern

Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. In addition, the company provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients. Further, it has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. Additionally, the company offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited was incorporated in 2014 and is headquartered in Guangzhou, China.

First Trust Multi Cap Value AlphaDEX Fund stock logo

First Trust Multi Cap Value AlphaDEX Fund NASDAQ:FAB

$107.55 +0.43 (+0.40%)
As of 08/21/2026 03:18 PM Eastern

The First Trust Multi Cap Value AlphaDEX Fund (FAB) is an exchange-traded fund that is based on the NASDAQ AlphaDEX Multi Cap Value index. The fund tracks an index that uses fundamental factors to select and weight value stocks from the Nasdaq US Select Indices. FAB was launched on May 8, 2007 and is managed by First Trust.

Nanalysis Scientific stock logo

Nanalysis Scientific CVE:NSCI

C$0.14 +0.01 (+3.57%)
As of 08/21/2026 12:10 PM Eastern

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries. The company is headquartered in Calgary, Canada.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas